middle.news
Why Anne Lockwood’s Interim MD Role Could Define Genetic Signatures’ Next Chapter
8:32am on Friday 6th of February, 2026 AEDT
•
Healthcare
Read Story
Why Anne Lockwood’s Interim MD Role Could Define Genetic Signatures’ Next Chapter
8:32am on Friday 6th of February, 2026 AEDT
Key Points
Anne Lockwood appointed interim Managing Director for six months
Appointment follows recent CEO and CFO resignations
Lockwood brings over 30 years of financial and governance experience
Permanent CFO appointment deferred during interim period
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE